NSCMB FEB RAS helps applied medicine: Synaptamide in the treatment of nerve injuries
![NSCMB FEB RAS helps applied medicine: Synaptamide in the treatment of nerve injuries](/assets/images/Olga/news/250x188/science_day_2022.jpg)
On the Russian Science Day February, 8, the A.V. Zhirmunsky National Scientific Center of Marine Biology FEB RAS in collaboration with the Primorsky Aquarium set up a new video project on the research and discoveries of the scientists working in the Center.
The first films is about the studies of synaptamide carried out by a team of scientists led by Igor Manzhulo, PhD, from the Laboratory of Pharmacology. Synaptamide is an endogenous metabolite of docosahexaenoic acid (omega-3 PUFA) that produces anti-inflammatory and neuroprotective effects on the peripheral and central nervous systems. It is also a promising therapeutic agent for the treatment of nerve injuries and concomitant memory deficits caused by neuroinflammation and neural tissue degradation.